Ken VanLuvanee, President & CEO It was a wonderful 2023 for the team at Facet Life Sciences. We had some fun, welcomed several new team members into the Facet family, joined hands with several new clients, and advanced s...

Ken VanLuvanee, President & CEO It was a wonderful 2023 for the team at Facet Life Sciences. We had some fun, welcomed several new team members into the Facet family, joined hands with several new clients, and advanced s...
From The Corner OfficeKen VanLuvanee, President & CEO It was a wonderful 2023 for the team at Facet Life Sciences. We had some fun, welcomed several new team members into the Facet family, joined hands with several new c...
We recently caught up with Jason Mercer, Strategic Program Champion at Facet Life Sciences about what it is like to work at facet and some of his favorite milestones. Favorite Projects One of my favorite projects was a combinat...
Congratulations to Dr. Jason Mercer ! Dr. Jason Mercer has been chosen to serve as a committee member on the Food and Drug Law Institute’s (FDLI) Medical Products committee this year. As part of the committee, Dr. Mercer...
Facet Life Sciences Holiday Gift Guide: Because Even Santa Needs Regulatory Expertise! US Agent – The Yuletide Ambassador: Gift the ‘US Agent’ service for the friend who needs a reliable representative i...
We recently caught up with Bill Hodnick, Product Development Champion at Facet Life Sciences about what it is like to work at facet and some of his favorite milestones. Favorite Projects I’ve worked on a lot of interestin...
FACET BY THE NUMBERS Total submissions to FDA July – Sept 2023: over 40 (over 3 submissions a week!) Early-stage development highlights: prepared/submitted 2 INDs for new chemical entities and over 30 IND amendments (e.g., new...
Partner News Facet is delighted to announce a partnership with Veramed. Veramed is a pioneering CRO redefining intelligent healthcare decision-making. As trusted industry specialists, Veramed’s global team provides next-level...
FDA ROUNDUP: FDA Issues New User Fees for 2023-2024 – Costs Are Going Up! If you are submitting an NDA or BLA application that includes clinical data in 2023 or 2024, you will pay $3.24M, and a whopping $4.04M, respectively! P...
DID YOU KNOW? Facet is on a mission to help small organizations bring great science and innovative products to and through FDA. Many small organizations waste significant money and time running large nonclinical programs to su...
gET sOCIAL